Ventilation parameters. by Zhiwei Li (131853)

“…Furthermore, PCV-VG was associated with an increased center of ventilation (45.1 ± 3.7 vs. 41.7 ± 3.5, P < 0.05), a decrease in global inhomogeneity (GI) (0.85 ± 0.16 vs. 1.06 ± 0.30, P < 0.05), and a reduction in regional ventilation delay index (RVDI) (10.5 ± 4.5 vs. 15.9 ± 5.3, P < 0.05), when compared to VCV. …”

Effect of NPRC KO on fibrotic markers. by Liming Wang (114648)

“…<p>(6A) The myofibroblast marker alpha-SMA was significantly increased in glomerular preparations from WT Gq mice compared to controls. …”

Simulations show that microSLAM improves power and false positive rates. by Miriam Goldman (21433180)

Multiple comparisons after ANOVA(CR10). by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

Homogeneity test of CR10. by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

Illustration of the fNIRS device worn. by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

Analysis of variance of HbO₂ in bilateral PFC. by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

fNIRS equipment coordinates. by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

Changes of muscle oxygen saturation. by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

Analysis of variance of CR10. by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

Placement on the forehead. by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

IMW intervention plan design. by Xinyu Dai (5100731)

“…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”

P_i‐treatment aggravates calcification and induces phenotypic transition of VSMCs. by Razia Rashid Rahil (22772495)

“…(B) Summarized bar graph showed P_i treatment significantly increased calcium deposition. Bar graphs depicted significant decrease in mRNA expression of (C) α -SMA (D) SM22α and increased (E) RUNX2 (F) OPN and (G) BMP2. …”

The effect of exposure to imidacloprid on the fat body of workerbees sampled from colonies fed diets with different additions of imidacloprid. by Jerzy Paleolog (3220308)

The effect of exposure to imidacloprid on the hemolymph of workerbees sampled from colonies fed diets with different additions of imidacloprid. by Jerzy Paleolog (3220308)

Effects of CER on vascular calcification and phenotypic change in P_i<i>‐</i>treated VSMCs. by Razia Rashid Rahil (22772495)

“…Bar graphs depicted significant decrease in mRNA expression of (C) α -SMA (D) SM22α and increased (E) RUNX2 (F) OPN and (G) BMP2 in CER treated P_i-induced VSMCs. …”

(1A) CNP is produced by podocytes and binds to both NPRB and NPRC on glomerular podocytes. by Liming Wang (114648)

Risk of bias across 22 included studie. by Kuo-Chuan Hung (8587392)

“…</p><p>Results</p><p>A meta-analysis of 22 RCTs (n = 3,463) showed that ketamine/esketamine significantly decreased PPD risk at 1- (risk ratio [RR], 0.41; 95% confidence interval [CI], 0.3–0.57) and 4–6-week (RR, 0.47; 95%CI, 0.35–0.63) follow-ups. …”

An overview of the selection process for studies. by Kuo-Chuan Hung (8587392)

“…</p><p>Results</p><p>A meta-analysis of 22 RCTs (n = 3,463) showed that ketamine/esketamine significantly decreased PPD risk at 1- (risk ratio [RR], 0.41; 95% confidence interval [CI], 0.3–0.57) and 4–6-week (RR, 0.47; 95%CI, 0.35–0.63) follow-ups. …”

Characteristics of studies (<i>n</i> = 22). by Kuo-Chuan Hung (8587392)

“…</p><p>Results</p><p>A meta-analysis of 22 RCTs (n = 3,463) showed that ketamine/esketamine significantly decreased PPD risk at 1- (risk ratio [RR], 0.41; 95% confidence interval [CI], 0.3–0.57) and 4–6-week (RR, 0.47; 95%CI, 0.35–0.63) follow-ups. …”